Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octaplas in pediatric patients requiring coagulation factor replacement
NCT02050841Phase 4Completed
- Sponsor
- Octapharma
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of octaplas lg in coagulopathy, sponsored by Octapharma. Started Dec 2014; status: completed.
02
Drugs
octaplas lg
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT02050841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050841.